Irish Pharmaceutical Healthcare Association (IPHA)

healthcare ireland medicines irish pharma ipha annual meeting 2009 pharmaceutical industry drugs ipha health service contribution value patients hse demographics challanges demographic trends development research global health r&d uhi universal healthcare insurance medicine health insurance healthcare funding vhi healthcare delivery regulation irish medicines board economy health technology assessment hta access value for money programme health care health service executive foreign direct investment fdi risk self-care arthritis mens health health service executice prescribing ageing population department of health and children self-medication exports chronic disease eli lilly gsk pfizer novo nordisk glaxosmithkline novartis wyeth abbott responsibility cr pharmaceutical csr astellas lundbeck sanofi merck